Palatin Technologies, Inc. (PTN) financial statements (2021 and earlier)

Company profile

Business Address 4B CEDAR BROOK DRIVE
CRANBURY, NJ 08512
State of Incorp. NJ
Fiscal Year End June 30
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
TTM
6/30/2020
6/30/2019
6/30/2018
6/30/2017
6/30/2016
6/30/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments7283443840827
Cash and cash equivalents7283443840827
Receivables5160 15  
Inventory, net of allowances, customer advances and progress billings6      
Inventory6      
Prepaid expense1 00000
Other undisclosed current assets2000132
Total current assets:858410439571129
Noncurrent Assets
Operating lease, right-of-use asset11
Property, plant and equipment0000000
Other noncurrent assets0000000
Total noncurrent assets:1101000
TOTAL ASSETS:878510539571129
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities64341287
Accounts payable1112211
Accrued liabilities53321186
Debt  06860
Other liabilities1 00   
Other undisclosed current liabilities00  35  
Total current liabilities:7441155147
Noncurrent Liabilities
Long-term debt and lease obligation11 061410
Long-term debt, excluding current maturities   061410
Capital lease obligations   00
Operating lease, liability11
Liabilities, other than long-term debt11  0100
Other liabilities11  0100
Other undisclosed noncurrent liabilities (1) 1   
Total noncurrent liabilities:121 171510
Total liabilities:195412622917
Stockholders' equity
Stockholders' equity attributable to parent688010127(5)(18)12
Preferred stock0000000
Common stock2222211
Additional paid in capital398396394357350325303
Accumulated other comprehensive loss    (0)(0) 
Accumulated deficit(332)(318)(296)(332)(357)(343)(292)
Total stockholders' equity:688010127(5)(18)12
TOTAL LIABILITIES AND EQUITY:878510539571129

Income statement (P&L) ($ in millions)

12/31/2020
TTM
6/30/2020
6/30/2019
6/30/2018
6/30/2017
6/30/2016
6/30/2015
Revenues(0)0606745 13
Revenue, net 45 13
Cost of revenue
(Other undisclosed Cost of revenue)
(0)      
Gross profit:(1)0606745 13
Operating expenses(26)(24)(25)(41)(55)(49)(30)
Other undisclosed operating income0      
Operating income (loss):(26)(24)3626(11)(49)(17)
Nonoperating income (expense)(0)1000(2)(1)
Investment income, nonoperating0100000
Foreign currency transaction loss, before tax(1)      
Other nonoperating expense      (0)
Interest and debt expense(0)(0)(0)(1)(2)(3)(1)
Income (loss) from continuing operations before income taxes:(27)(22)3525(13)(54)(19)
Income tax expense (benefit)   (0)(1) 1
Net income (loss):(27)(22)3525(13)(54)(18)
Other undisclosed net income attributable to parent000  31
Net income (loss) available to common stockholders, diluted:(27)(22)3625(13)(52)(18)

Comprehensive Income ($ in millions)

12/31/2020
TTM
6/30/2020
6/30/2019
6/30/2018
6/30/2017
6/30/2016
6/30/2015
Net income (loss):(27)(22)3525(13)(54)(18)
Comprehensive income (loss):(27)(22)3525(13)(54)(18)
Other undisclosed comprehensive income, net of tax, attributable to parent000003 
Comprehensive income (loss), net of tax, attributable to parent:(27)(22)3625(13)(52)(18)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: